Morphosys Ag ADR (MOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Sales | 20,298 | 277,149 | 12,154 | 13,870 | 38,954 |
| Cost of Goods | -7,959 | 3,596 | 1,279 | 1,080 | 5,532 |
| Gross Profit | 28,256 | 273,553 | 10,875 | 12,790 | 33,422 |
| Operating Expenses | 80,554 | 49,630 | 68,031 | 43,839 | 40,250 |
| Operating Income | -53,257 | 224,519 | -56,877 | -30,969 | -6,297 |
| Interest Expense | 27,611 | 10,246 | 1,527 | 240 | 495 |
| Other Income | 17,018 | 22,267 | -1,477 | 3,629 | 308 |
| Pre-tax Income | -63,850 | 236,540 | -59,880 | -27,580 | -6,484 |
| Income Tax | -5,394 | 20,851 | -3,699 | -719 | 102 |
| Net Income Continuous | -58,456 | 215,689 | -56,181 | -26,861 | -6,586 |
| Net Income | $-58,456 | $215,689 | $-56,181 | $-26,861 | $-6,586 |
| EPS Basic Total Ops | -0.45 | 1.69 | -0.44 | -0.21 | -0.05 |
| EPS Basic Continuous Ops | -0.45 | 1.69 | -0.44 | -0.21 | -0.05 |
| EPS Diluted Total Ops | -0.45 | 1.69 | -0.44 | -0.21 | -0.05 |
| EPS Diluted Continuous Ops | -0.45 | 1.68 | -0.44 | -0.21 | -0.05 |
| EBITDA(a) | $-51,226 | $226,559 | $-55,015 | $-29,277 | $-4,598 |